FDA accepts Takeda's application for pediatric ENTYVIO treatment

Go back to FDA accepts Takeda's application for pediatric ENTYVIO treatment
(NYSE: TAK) Delayed: 18.05 +0.67 (3.86%)
Previous Close $17.38    52 Week High $0.55 
Open $17.86    52 Week Low $0.55 
Day High $18.16    P/E N/A 
Day Low $17.83    EPS $-0.20 
Volume 3,809,699